Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

  • This share is currently suspended. It was suspended at a price of 0.25
  • There is currently no data for TLY

Director/PDMR Shareholding

2 Oct 2008 09:37

2 October 2008 Totally plc (`'Totally'' or `'the Company'') Issue of warrants

In the announcement made on 1 September 2008 relating to the disposal of a trading subsidiary, the Company announced that The Zvhil-Mezbuz Rebbe, Grand Rabbi Y.A. Korff of Boston ("the Rebbe") would be released from his obligations under the guarantee to Bank Hapoalim to support the Company's banking facility. The guarantee to Bank Hapoalim to support the extended credit facility of ‚£ 700,000 for the Company would be provided by Leo Noƒ©, a third party shareholder, and Dr Michael Sinclair, Non-Executive Chairman (together the "Guarantors").

In addition, the Company stated that it was the intention of the Board to issue warrants to Leo Noĩ and Dr Sinclair as guarantors of the facility in the near future in recognition of the increase in their personal guarantees.

Following approval of the resolutions at the general meeting of the Company held on 25 September 2008 and in accordance with the terms of the Jewish Advocate Publishing Corporation share purchase agreement, the Company has today cancelled warrants to subscribe for 4,394,350 ordinary shares which had been issued to the Rebbe.

Furthermore, owing to the exercise price of all of the warrants previously issued in relation to the personal guarantees to Bank Hapoalim to support the Company's overdraft facility being significantly above the current share price, the Company has agreed to cancel all the warrants issued to Dr Sinclair and Leo Noĩ and to replace the cancelled warrants, by issuing 35,000,000 warrants to each of Dr Sinclair and Leo Noĩ in recognition of the fact that the Guarantors have continued to provide personal guarantees to Bank Hapoalim.

The warrants are exercisable immediately from the date of issue for a period of five years at an exercise price of 1 penny per share, being the nominal value of the Company's ordinary shares, which is a premium of 132.5 per cent over the closing middle-market price on 1 October 2008.

At the date of this announcement, Dr Sinclair holds 14,509,791 ordinary shares and warrants over 35,000,000 ordinary shares exercisable at one penny per share. Mr Noĩ currently holds 6,666,666 ordinary shares and warrants over 35,000,000 ordinary shares exercisable at one penny per share.

Following the issue of the new warrants detailed above there will be warrants outstanding over 90,123,013 Ordinary Shares, equivalent to 98.02 per cent. of the issued voting share capital of the Company, which are exercisable at exercise prices ranging from 1 to 5 pence per share.

At the date of this announcement the Company has 91,947,934 ordinary voting shares in issue.

If Dr Sinclair were to exercise his warrants and no other shares in the Company were to be issued, Dr Sinclair would hold 49,509,791 ordinary shares, representing 39.00 per cent. of the then enlarged issued share capital. If Leo Noĩ were to exercise his warrants and no other shares in the Company were issued, Mr Noĩ would hold 41,666,666 ordinary shares, equivalent to 32.82 per cent. of the then enlarged issued share capital. In addition, if both Dr Sinclair and Mr Noĩ were to exercise their warrants and no other shares in the Company be issued, between them they would hold 91,176,457 ordinary shares, equivalent to 56.30 per cent. of the then enlarged issued share capital.

Were either of Dr Sinclair or Mr Noĩ to exercise their warrants, to such an extent that individually they would hold 30 per cent. or more of the then issued share capital, they would first need to be granted a waiver of Rule 9 of the Takeover Code, which would need to be approved by shareholders of the Company at a general meeting.

Under the AIM Rules, the issue of the warrants is classified as a related party transaction. The directors, other than Dr Michael Sinclair, who is interested in the warrant issue, (the "Independent Directors") who have consulted with John East & Partners Limited, consider the terms of the warrant issue to be fair and reasonable insofar as the shareholders are concerned. In advising the Independent Directors, John East & Partners Limited has relied upon their commercial assessment.

For further information:

Totally Plc www.totallyplc.com T: 020 7692 6929

Daniel Assor CEO John East & Partners Limited T: 020 7628 2200

David Worlidge / Simon Clements HB Corporate T: 020 7510 8654

Luke Cairns

vendor
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - Totally Plc
9th Jun 20257:00 amRNSAdministration and Director Resignations
6th Jun 20251:00 pmRNSIntention to Appoint Administrators and Suspension
6th Jun 20251:00 pmRNSSuspension - Totally plc
30th May 20252:25 pmRNSHolding(s) in Company
29th May 20252:10 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSUpdate on Strategic Review
2nd May 20257:00 amRNSHolding(s) in Company
1st May 20257:00 amRNSCommencement of Strategic Review
1st May 20257:00 amRNSTrading Update
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20253:35 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20253:15 pmRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSContract Renewals
26th Feb 20251:00 pmRNSHolding(s) in Company
25th Feb 20256:00 pmRNSHolding(s) in Company
25th Feb 202511:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirectorate Change
20th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20257:00 amRNSOutlook Update
13th Jan 20257:00 amRNSDirectorate Change
7th Jan 20254:15 pmRNSHolding(s) in Company
3rd Dec 20244:00 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSInterim Results
5th Nov 20245:00 pmRNSHolding(s) in Company
31st Oct 20247:00 amRNSUpdate on Banking Facility
17th Oct 20247:00 amRNSNotice of Interim Results & Investor Presentation
27th Sep 20245:45 pmRNSResult of AGM
27th Sep 20249:00 amRNSAGM Statement
27th Sep 20247:00 amRNSContract Win and Extension
20th Sep 20242:30 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20241:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20247:00 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSContract Wins
27th Aug 20246:16 pmRNSHolding(s) in Company
27th Aug 20246:13 pmRNSHolding(s) in Company
2nd Aug 20249:30 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSDirectorate Change
1st Aug 202410:45 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSContract extensions and win
22nd Jul 20243:30 pmRNSHolding(s) in Company
18th Jul 20247:00 amRNSNotice of Results
11th Jul 20247:00 amRNSContract extensions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.